Related Experiment Video
Updated: Nov 13, 2025

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
Systemic lupus erythematosus and COVID-19 during pregnancy
Hieronymus Tw Smeele1, Luis F Perez-Garcia1, Koen Grimminck1,2
1Department of Rheumatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Insights
Pregnant patients with systemic lupus erythematosus (SLE) experiencing mild COVID-19 infection can often be managed with watchful waiting. Both pregnancies resulted in healthy term neonates, emphasizing individualized care during the pandemic.
Area of Science:
- Obstetrics and Gynecology
- Rheumatology
- Infectious Diseases
Background:
- The COVID-19 pandemic presents unique challenges for pregnant individuals, particularly those with autoimmune conditions like systemic lupus erythematosus (SLE).
- Limited data exists on the clinical presentation and management of COVID-19 in pregnant SLE patients.
Observation:
- This report details two pregnant patients with SLE who contracted mild symptomatic COVID-19.
- A conservative watchful-waiting approach was adopted for COVID-19 management in both cases, without initiating specific antiviral treatments.
Findings:
- Both pregnancies proceeded without adverse events, culminating in the delivery of healthy neonates at full term.
- One patient experienced a lupus flare, potentially linked to the temporary discontinuation of SLE treatment.
Implications:
- Multidisciplinary collaboration and individualized treatment are crucial for managing pregnant SLE patients during the COVID-19 pandemic.
- Decisions regarding immunosuppressive therapy in pregnant SLE patients with COVID-19 should be made on a case-by-case basis, balancing risks and benefits.
- Treatment strategies must align with current guidelines for rheumatic diseases and pregnancy during infectious disease outbreaks.
Abstract:
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is currently lacking. Methods: Herein, we describe the clinical presentation of 2 pregnant patients with SLE and mild symptomatic COVID-19 infection. Results: In both pregnant SLE patients, a watchful-waiting approach without initiation of treatment for COVID-19 was taken. No adverse outcomes were reported and both pregnancies resulted in healthy neonates born at term. In one patient we observed a flare in SLE disease activity, most likely attributed to discontinuing SLE treatment. Conclusion: Our report highlights the importance of multidisciplinary collaboration between health care professionals as well as individualized treatment decisions during unprecedented periods such as the current COVID-19 pandemic. Discontinuation of immunosuppressive drugs during the acute phase of a COVID-19 infection should be considered on a case-by-case basis. Maternal treatment decisions should be in line with current recommendations for treatment of rheumatic and musculoskeletal diseases during COVID-19 infection and in line with treatment of COVID- 19 during pregnancy.
More Related Videos
07:13Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C
Published on: March 25, 2016
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Related Concept Videos
Sexually Transmitted Infections
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Teratogenicity
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Diabetes Mellitus: Type 2 and Gestational